WDTC1

WD and tetratricopeptide repeats 1, the group of Tetratricopeptide repeat domain containing|WD repeat domain containing|DDB1 and CUL4 associated factors

Basic information

Region (hg38): 1:27234632-27308636

Links

ENSG00000142784NCBI:23038OMIM:619763HGNC:29175Uniprot:Q8N5D0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the WDTC1 gene.

  • not_specified (52 variants)
  • not_provided (5 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDTC1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001276252.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
4
missense
52
clinvar
52
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 52 0 4
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
WDTC1protein_codingprotein_codingENST00000361771 1574104
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.000849125738041257420.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.812094320.4840.00002754457
Missense in Polyphen42168.110.249831679
Synonymous0.6381621730.9380.00001101323
Loss of Function4.90333.70.08910.00000175374

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.000.00
East Asian0.00006770.0000544
Finnish0.00004630.0000462
European (Non-Finnish)0.000008790.00000879
Middle Eastern0.00006770.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. {ECO:0000269|PubMed:16964240}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Neddylation (Consensus)

Recessive Scores

pRec
0.149

Intolerance Scores

loftool
0.0872
rvis_EVS
-0.44
rvis_percentile_EVS
24.46

Haploinsufficiency Scores

pHI
0.987
hipred
Y
hipred_score
0.825
ghis
0.529

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.985

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Wdtc1
Phenotype
growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype;

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;in utero embryonic development;glucose metabolic process;regulation of cell size;protein ubiquitination;cellular response to insulin stimulus;multicellular organism growth;negative regulation of catalytic activity;post-translational protein modification;negative regulation of fatty acid biosynthetic process;cellular chemical homeostasis
Cellular component
nucleoplasm;cytosol
Molecular function
enzyme inhibitor activity;protein binding;histone binding;histone deacetylase binding